Conducting a
Benefits Investigation (BI)

Although EYLEA is covered by most payers, it's important that you understand patient-specific insurance benefits and plan restrictions. Before a patient starts EYLEA treatment, it is recommended that you conduct a BI by completing and submitting an EYLEA4U® Enrollment Form.

Once you complete the EYLEA4U Enrollment Form and EYLEA4U confirms patient insurance benefits via the BI, you’ll find a wide array of support and solutions available.

EYLEA4U® logo

The Enrollment Form

Allows EYLEA4U to verify insurance coverage and determine program eligibility based on the support requested. The following support is available:

  • BI
  • Copay Assistance
  • Claims Assistance
  • Appeals Support
  • Prior Authorization (PA) Assistance
  • Patient Assistance Program (PAP)
EYLEA® (aflibercept) Injection enrollment form icon

Submit the completed form by fax to 1-888-335-3264 or complete electronically via the EYLEA4U e-Portal*

Visit the portal

*A completed and patient-signed form must be retained on file at the office for submissions entered via the e-Portal.

EYLEA4U Enrollment Form

Complete the EYLEA4U Enrollment Form to begin the process of helping your patients receive assistance.
Refer to the EYLEA4U Enrollment and BI Results Guide to learn more about filling out the appropriate forms.

{{DownloadFormModel.OutputFileName}}.zip  {{DownloadFormModel.DownloadSize}} MB
Support for the reimbursement process
EYLEA® (aflibercept) Injection benefits investigation

Understanding the
BI results

EYLEA4U support includes a thorough BI that—within 2 business days—summarizes your patient's coverage, PA requirements, cost responsibility, and any additional coverage information.

This comprehensive report is communicated by fax or via the EYLEA4U e-Portal within 2 business days of enrollment submission. Learn how to understand these BI results by downloading the helpful guide below.

PA Assistance

Some insurance plans may require a PA before considering coverage for EYLEA. If required, our Reimbursement Specialists at EYLEA4U can review and provide information on the PA requirements for a specific payer.

{{DownloadFormModel.OutputFileName}}.zip  {{DownloadFormModel.DownloadSize}} MB

Claims and appeals support

EYLEA4U is available to support your office with claims and appeals assistance. If you have questions or need information to prepare a claim, we’re here to help. We can also check the status of an existing claim with the patient’s insurer. Simply contact one of our knowledgeable Reimbursement Specialists.

If you received an underpaid or denied claim for EYLEA, we can provide you with information on how to resolve the issue. We can also research and explain the insurer’s appeal process in detail.

{{DownloadFormModel.OutputFileName}}.zip  {{DownloadFormModel.DownloadSize}} MB
EYLEA4U® logo

We have one-on-one reimbursement solutions and are here to help you through the entire reimbursement process

In addition to the BI, EYLEA4U Reimbursement Specialists can help with the following:

Claims Assistance:

  • Address questions on claims preparation
  • Review the status of an EYLEA claim with the patient's insurer

Appeals Assistance:

  • Provide information for resolving underpaid or denied claims or PAs for EYLEA
  • Explain the insurer's appeals process

Resource Center

Visit this helpful library to find enrollment forms, sample appeal letters, and more.

EYLEA® (aflibercept) Injection documents icon
EYLEA® (aflibercept) Injection ICD-10 icon

ICD-10 Code Finder

Use the interactive code finder to quickly find the current ICD-10 codes for EYLEA.

Find out more about EYLEA's flexible dosing options for certaian approved indications in a 2mg formulation.
Dosing with EYLEA

EYLEA offers flexible dosing options
for certain approved indications in a single 2mg formulation.

Find out more
Product support for Eylea
Product Support

Find complete product support—
guiding you through
orders, returns, and more.

Learn how it works
EYLEA news, events, and more

Keep up to date on
current EYLEA clinical information,
events, and more.

Read the latest
See More Important Safety Information and Indications
  • EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05 mL) is indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.

The information provided in this site is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries.